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bstract
Annulated pyrano[2,3-d]pyrimidine derivatives were synthesized via one-pot, three-component condensation reactions of various
romatic aldehydes, malononitrile and barbituric acid in aqueous ethanol using dibutylamine (DBA) as catalyst. The potential
pplication of DBA in organic synthesis is increasing rapidly due to its reaction simplicity, minimal reaction time, high yields of the
esired products (83–94%) and low cost chemicals. All of the synthesized pyrano[2,3-d]pyrimidine derivatives were characterized
1 13y IR, H NMR, C NMR and mass spectra.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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BA catalyst.  Introduction
Heterocyclic compounds have received considerable
ttention in recent years due to their variety of biologi-
al activities, especially as inhibitors of PDE5 extracted
rom human platelets [1], HIV-1 reverse transcriptase
2], human EPK2 [3] and cyclin-dependent kinase [4].
he study of aromatic six membered N-heterocyclic
ings is of great importance in the pharmaceutical
ector due to bio-isosteric factors, which are of the-∗ Corresponding author. Tel.: +91 08087723120;
ax: +91 07122500429.
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658-3655 © 2015 The Authors. Production and hosting by Elsevier B.V. on 
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).oretical and practical importance. Pyrimidine rings
have significant pharmacological importance as an inte-
gral part of DNA and RNA in several biological
processes [5–7]. Therefore, the chemotherapeutic effi-
cacy of annulated pyrano[2,3-d]pyrimidines is related
to their ability to inhibit enzyme action for DNA
biosynthesis, such as dihydrofolate reductase (DHFR),
thymidylate synthetase (TSase), thymidine phosphory-
lase (TPase) and reverse transcriptase (RTase). When
pyrano[2,3-d]pyrimidine moieties are annulated into
one molecule, the resultant derivative has enhanced
pharmaceutical activity, such as, antitumor [8], anti-
hypertensive [9], antibacterial [10] and antileishmanial
activity [11]. Therefore, for the preparation of these com-
plex molecules, large efforts have been made towardsbehalf of Taibah University. This is an open access article under the
the synthetic manipulation of annulated uracils, which
occupy a distinct and unique place in medicinal chem-
istry. Annulated pyrano[2,3-d]pyrimidine derivatives are
unsaturated N-heterocyclics formed as a fusion of pyran
h Unive10 A.R. Bhat et al. / Journal of Taiba
and pyrimidine rings, consisting of one oxygen atom
at 8 and two nitrogen atoms at the 1 and 3 pos-
itions. They are synthesized by various procedures based
on multicomponent reactions, such as Knoevenagel
condensation, Michael addition followed by cyclodehy-
dration and finally heterocyclization.
Multicomponent reactions (MCRs) have gained
significant interest from modern medicinal and com-
binatorial chemists [12,13] due to the powerful bond
forming efficiency, diversity-oriented synthesis (DOS),
simple reaction design, atom-economy, environmental
concerns and the possibility to construct target com-
pounds using several assorted elements in a single
chemical procedure [14,15]. Pyrano[2,3-d]pyrimidine
derivatives have been reported using different cata-
lysts, such as Zn[(l)proline]2 [16], [BMIm]BF4 [17],
N-methylmorpholine [18], DAHP [19], SBA-Pr-SO3H
[20], H14[NaP5W30O110] [21], 1,4-dioxane [22], l-
proline [23] and [K Al(SO4)2] [24]. Et3N was
used as a catalyst for the synthesis of pyrano[2,3-
d]pyrimidine derivatives under microwave irradiation
[25]. A catalyst-free procedure was also examined for
the preparation of pyrano[2,3-d]pyrimidine derivatives
[26]. In addition, ultrasonic irradiation [27] and ball-
milling techniques [28] were used for the synthesis of
pyrano[2,3-d]pyrimidine derivatives. The solvent and
the inexpensive, mild and reusable catalyst for MCRs
play an important role in the synthesis and its selectivity
of targeted products. One of these catalysts is dibuty-
lamine (DBA), which has received significant interest
as a high reactive, eco-friendly, inexpensive, readily
available and non-toxic catalyst to obtain corresponding
products in excellent yields with high selectivity [29].
In continuation of the current research from
our laboratory to develop efficient multicomponent
reactions (MCRs) for the preparation of pyrimidine-
annulated bioactive molecules [30], we report here,
the dibutylamine (DBA) catalyzed efficient, sim-
ple and fast synthesis of pyrano[2,3-d]pyrimidine
derivatives via one-pot, three-component domino
Knoevenagel–Michael addition reaction in aqueous
media (Scheme 1).
2.  Experimental
2.1.  Apparatus  and  analysis
All chemicals were obtained from Merck and S.D.
Fine Chem. Co. and were used without further purifi-
cation. Melting points were determined by the open
capillary method and were uncorrected. IR spectra were
recorded on a Perkin–Elmer 298 spectrophotometerrsity for Science 10 (2016) 9–18
using KBr pellets. 1H and 13C NMR spectra were
recorded using a Bruker instrument (1H at 400 MHz
and 13C at 100 MHz) in DMSO-d6 solvent with tetram-
ethylsilane as the internal standard. Chemical shifts
are reported in ppm. Mass spectra were recorded on
a Shimadzu GC-MS-QP-2010 model using the direct
injection probe technique. Reactions were monitored by
thin-layer chromatography on 0.2-mm precoated plates
of silica gel G60 F254 (Merck).
2.2.  General  procedure  for  the  synthesis  of
pyrano[2,3-d]pyrimidine  derivatives  4(a–j)
Substituted aromatic aldehydes 1 (1 mmol), malonon-
itrile 2  (1 mmol), barbituric acid 3  (1 mmol) and 20 mol%
dibutylamine (DBA) were added to an RB flask with
16 ml aqueous media (1:1 ratio) and were stirred for
43–129 min at room temperature. The progress of the
reaction was monitored by TLC. The solid product was
filtered, washed with cold water and recrystallized from
ethanol to obtain pure pyrano[2,3-d]pyrimidine deriva-
tives with excellent yields (83–94%).
2.3.  Spectral  data  for  the  synthesized
pyrano[2,3-d]pyrimidine  derivatives  4(a–j)
2.3.1.  7-Amino-5-(4-nitrophenyl)-2,4-dioxo-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
carbonitrile  (4a)
White powder, IR (KBr, ν  cm−1): 3411 (NH2), 3209,
3163 (NH), 2989 (C H), 2206 (C N), 1732 (C O), 1461
(C C). 1H NMR (400 MHz, DMSO-d6): δ  = 13.01 (s,
1H, NH), 8.93 (s, 1H, NH), 7.94 (d, J  = 7.1 Hz, 2H, Ar-
H), 7.47 (d, J = 7.1 Hz, 2H, Ar-H), 6.79 (s, 2H, NH2),
4.96 (s, 1H, CH) ppm; 13C NMR (100 MHz, DMSO-
d6): δ = 176.47 (C O), 170.60 (CNH2), 153.93 (CONH),
151.36 (C O), 150.32 (C-14), 147.44 (C-11), 128.99 (C-
12), 123.19 (C-13), 120.41 (C N), 104.46 (C-5), 75.53
(C-9), 70.70 (C-10) ppm; MS (m/z): 328.2 [M+H+].
2.3.2. 7-Amino-5-(3-nitrophenyl)-2,4-dioxo-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
carbonitrile  (4b)
White powder, IR (KBr ν  cm−1): 3314 (NH2), 3301,
3247 (NH), 2942 (C H), 2212 (C N), 1605 (C O), 1476
(C C). 1H NMR (400 MHz, DMSO-d6): δ  = 12.02 (s,
1H, NH), 10.21 (s, 1H, NH), 8.38 (s, 1H, Ar-H), 8.19 (d,
J = 6.3 Hz, 2H, Ar-H), 6.82 (s, 2H, NH2), 3.94 (s, 1H,
CH) ppm; 13C NMR (100 MHz, DMSO-d6): δ  = 166.12
(C O), 160.73 (CNH2), 157.01 (CONH), 151.56 (C O),
150.57 (C-14), 146.11 (C-11), 129.23 (C-12), 123.08
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C-13), 119.45 (C N), 104.42 (C-5), 79.32 (C-9), 71.10
C-10) ppm; MS (m/z): 328.2 [M+H+].
.3.3. 7-Amino-5-(2-nitrophenyl)-2,4-dioxo-2,3,4,5-
etrahydro-1H-pyrano[2,3-d]pyrimidine-6-
arbonitrile  (4c)
White powder, IR (KBr ν  cm−1): 3302 (NH2), 3331,
142 (NH), 2938 (C H), 2172 (C N), 1645 (C O),
527 (C C). 1H NMR (400 MHz, DMSO-d6): δ = 10.12
s, 1H, NH), 10.79 (s, 1H, NH), 7.69–7.63 (m, 3H,
r-H), 6.82 (s, 2H, NH2), 3.94 (s, 1H, CH) ppm; 13C
MR (100 MHz, DMSO-d6): δ  = 179.44 (C O), 170.14
CNH2), 159.59 (CONH), 156.79 (C O), 149.87 (C-14),
34.52 (C-11), 132.12 (C-12), 130.05 (C-13), 127.31
C N), 91.81 (C-5), 84.24 (C-9), 57.01 (C-10) ppm; MS
m/z): 350.02 [M+Na+].
.3.4. 7-Amino-5-(4-hydroxyphenyl)-2,4-dioxo-
,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
arbonitrile  (4d)
Yellow powder, IR (KBr, ν  cm−1): 3457 (OH), 3260
NH2), 3131, 3088 (NH), 2293 (C H), 2242 (C N),
729 (C O), 1678 (C O), 1555 (C C). 1H NMR
400 MHz, DMSO-d6): δ  = 10.87 (s, 1H, NH), 10.79 (s,
H, NH), 6.98 (d, J = 7.5 Hz, 2H, Ar-H), 6.82 (s, 2H,
H2), 6.61 (d, J  = 7.6 Hz, 2H, Ar-H), 6.05 (s, 1H, OH),
.31 (s, 1H, CH) ppm; 13C NMR (100 MHz, DMSO-
6): δ  = 168.93 (C O), 157.19 (C-14), 155.61 (CNH2),
53.38 (CONH), 152.72 (C O), 129.32–129.20 (C-12 &
-16), 118.20 (C N), 115.16 (C-13), 97.22 (C-5), 58.65
C-9), 54.87 (C-10) ppm; MS (m/z): 298.06 [M+H+].
.3.5. 7-Amino-5-(3-hydroxyphenyl)-2,4-dioxo-
,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
arbonitrile  (4e)
Yellow powder, IR (KBr, ν  cm−1): 3439 (OH), 3337
NH2), 3193, 3028 (NH), 2206 (C H), 2131 (C N),
677 (C O), 1625 (C O), 14,741 (C C); 1H NMR pyrano[2,3-d]pyrimidines 4(a–j).
(400 MHz, DMSO-d6): δ = 12.04 (s, 1H, NH), 10.62 (s,
1H, NH), 6.97–6.83 (m, 3H, Ar-H), 6.61 (s, 2H, NH2),
6.09 (s, 1H, OH), 3.94 (s, 1H, CH); 13C NMR (100 MHz,
DMSO-d6): δ  = 179.43 (C O), 170.23 (C-14), 159.49
(CNH2), 157.19 (CONH), 155.08 (C O), 129.31 (C-16),
129.20 (C N), 115.15 (C-13), 93.41 (C-5), 84.21 (C-9),
52.03 (C-10); MS (m/z): 299.02 [M+H+].
2.3.6. 7-Amino-5-(4-bromophenyl)-2,4-dioxo-
2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
carbonitrile  (4f)
White powder, IR (KBr, ν  cm−1): 3370 (NH2), 3340,
3189 (NH), 3080 (C H), 2220 (C N), 1684 (C O), 1567
(C C). 1H NMR (400 MHz, DMSO-d6): δ = 14.10 (s,
1H, NH), 13.01 (s, 1H, NH), 7.75 (d, J  = 7.1 Hz, 2H, Ar-
H), 7.33 (d, J = 7.1 Hz, 2H, Ar-H), 6.82 (s, 2H, NH2),
3.90 (s, 1H, CH) ppm; 13C NMR (100 MHz, DMSO-
d6): δ  = 173.47 (C O), 160.34 (CNH2), 153.89 (CONH),
145.91 (C O), 138.53 (C-11), 131.97 (C-13 & C-15),
129.69 (C-12 & C-16), 124.03 (C-14), 121.28 (C N),
105.25 (C-5), 69.60 (C-9), 50.10 (C-10) ppm; MS (m/z):
384.12 [M+Na+].
2.3.7. 7-Amino-2,4-dioxo-5-phenyl-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-
carbonitrile  (4  g)
Yellow powder, IR (KBr, ν cm−1): 3371 (NH2), 3301,
3212 (NH), 3114 (C H), 2129 (C N), 1694 (C O), 1572
(C C). 1H NMR (400 MHz, DMSO-d6): δ = 10.98 (s,
1H, NH), 10.80 (s, 1H, NH), 7.31 (t, J  = 7.3 Hz, 2H,
Ar-H), 7.14–7.06 (m, 3H, Ar-H), 6.82 (s, 2H, NH2),
4.29 (s, 1H, CH) ppm; 13C NMR (100 MHz, DMSO-
d6): δ  = 160.39 (C O), 155.61 (CNH2), 153.91 (CONH),
151.36 (C O), 145.92 (C-11), 128.68 (C-12), 128.49 (C-
13), 127.61 (C-14), 118.21 (C N), 93.41 (C-5), 58.66
(C-9), 50.89 (C-10) ppm; MS (m/z): 283.08 [M+H+].
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2.3.8.  7-Amino-5-(4-methoxyphenyl)-2,4-dioxo-
1,3,4,5-tetrahydro-2H-pyrano[2,3-d]
pyrimidine-6-carbonitrile  (4  h)
Dark yellow powder, IR (KBr, ν  cm−1): 3317 (NH2),
3282, 3145 (NH), 3063 (C H), 2215(C N), 1743
(C O), 1668 (C C). 1H NMR (400 MHz, DMSO-d6):
δ = 10.98 (s, 1H, NH), 10.80 (s, 1H, NH), 7.14 (d,
J = 7.5 Hz, 2H, Ar-H), 6.86–6.82 (m, 4H, Ar-H & NH2),
4.16 (s, 1H, CH), 3.81 (s, 3H, OCH3) ppm; 13C NMR
(100 MHz, DMSO-d6): δ = 161.99 (C O), 159.11 (C-
14), 155.61 (CNH2), 151.97 (CONH), 151.36 (C O),
130.34 (C-11), 129.50 (C-12), 123.56 (C N), 113.14
(C-13), 93.41 (C-5), 58.66 (C-9), 57.46 (CH3), 53.46
(C-10) ppm; MS (m/z): 313.01 [M+H+].
2.3.9. 7-Amino-5-(2-methoxyphenyl)-2,4-dioxo-
1,3,4,5-tetrahydro-2H-pyrano[2,3-d]
pyrimidine-6-carbonitrile  (4i)
Yellow powder, IR (KBr, ν  cm−1): 3419 (NH2), 3202,
3137 (NH), 3016 (C H), 2272(C N), 1765 (C O), 1609
(C C). 1H NMR (400 MHz, DMSO-d6): δ  = 10.93 (s,
1H, NH), 10.71 (s, 1H, NH), 7.44 (d, J  = 4.6 Hz, 1H, Ar-
H), 7.14–7.7.11 (m, 4H, Ar-H & NH2), 4.16 (s, 1H, CH),
3.73 (s, 3H, OCH3) ppm; 13C NMR (100 MHz, DMSO-
d6): δ  = 169.87 (C O), 161.02 (C-14), 158.21 (CNH2),
152.46 (CONH), 151.82 (C O), 131.15 (C-11), 129.09
(C-12), 124.02 (C N), 113.18 (C-13), 94.39 (C-5), 58.93
(C-9), 57.41 (CH3), 53.57 (C-10) ppm; MS (m/z): 313.05
[M+H+].
2.3.10.  7-Amino-5-(3,4-dimethoxyphenyl)-2,4-
dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-
d]pyrimidine-6-carbonitrile
(4j)
Yellow powder, IR (KBr, ν  cm−1): 3194 (NH2), 3103,
2223 (NH), 1734 (C H), 2609 (C N), 1662 (C O),
1262 (C C). 1H NMR (400 MHz, DMSO-d6): δ  = 10.98
(s, 1H, NH), 10.80 (s, 1H, NH), 6.83–6.80 (m, 5H,
Ar-H & NH2), 4.29 (s, 1H, CH), 3.83 (s, 3H, OCH3),
3.75 (s, 3H, OCH3) ppm; 13C NMR (100 MHz, DMSO-
d6): δ  = 164.65 (C O), 155.61 (CNH2), 153.94 (CONH),
151.97 (C O), 149.25 (C-14), 148.54 (C-13), 131.34
(C-11), 126.92 (C-16), 119.53 (C N), 116.52 (C-12),
114.27 (C-15), 93.40 (C-5), 58.66 (C-9), 57.91 (CH3),
56.78 (CH3), 51.23 (C-10) ppm; MS (m/z): 343 [M+H+].
3.  Results  and  discussionHerein, we report the synthesis of pyrano[2,3-
d]pyrimidinones (4a–j) through domino Knoevenagel–
Michael condensation pathways (Table 1). In the
initial studies, hydroxybenzaldehyde 1 (1.0 mmol),rsity for Science 10 (2016) 9–18
malononitrile 2  (1.0 mmol) and barbituric acid 3
(1.0 mmol) were refluxed in aqueous ethanol using dif-
ferent catalysts for the synthesis of model product 4d.
We found the base catalysts, such as N-methylimidazole,
triethylamine, piperidine, morpholine and dibutylamine
(Table 2), were equally competent in furnishing the
desired model product 4d  in good yields. Among these
basic catalysts, 20 mol% of dibutylamine (DBA) gave the
best result in terms of time of completion, and the product
yield was 94%. In the absence of catalyst, the reaction
was completed under reflux conditions after 189 min,
and the yield of product was 37% (Table 2). Therefore,
dibutylamine (DBA) catalyst is superior to all of the other
tested catalysts.
Further, we focused on the systematic evaluation
of different solvents, such as ethanol:H2O, DMF,
CH2Cl2 and 1,4-dioxane (Table 3, entry 1–6), for
the model reaction 4 using hydroxybenzaldehyde 1
(1.0 mmol), malononitrile 2  (1.0 mmol) and barbituric
acid 3  (1.0 mmol) as reactants in presence of 20 mol%
dibutylamine (DBA) catalyst (Scheme 2). The results
indicated that the solvent has a significant effect on the
product yield and reaction time. The best conversion was
observed when the reaction proceeded in ethanol:H2O
(Table 3, entry 1). The use of aqueous ethanol as sol-
vent in the reaction medium exhibits remarkable benefits,
such as environmentally safe, devoid of carcinogenic
effects, comparatively cheaper to operate and simple
work up. Table 4 shows the comparative results of the
different catalysts with the catalytic activity of DBU for
the synthesis of pyrano[2,3-d]pyrimidine derivatives.
The structural assignment of model product 4d
was confirmed by IR, 1HNMR, 13CNMR and mass
spectrometric analysis. The IR spectra exhibited sharp
absorption bands at 3457, 3260, 3131–3088, 2293, 1729,
1678 and 1555 cm−1, which are attributed to OH, NH2,
NH, C H, C N, C O and C C stretching vibrations,
respectively. The 1H NMR spectrum of compound 4d
had peaks at δ  10.87 (s, 1H, NH), δ  10.79 (s, 1H, NH), δ
6.98 (d, J = 7.5 Hz, 2H, Ar-H), δ 6.82 (s, 2H, NH2), δ  6.61
(d, J = 7.6 Hz, 2H, Ar-H), δ  6.05 (s, 1H, OH) and δ  4.31
(s, 1H, CH) ppm (Fig. 1). In the 13CNMR spectrum of
the compound 4d, 12 significant signals were recorded at
168.93, 157.19, 155.61, 153.38, 152.72, 129.32–129.20,
118.20, 115.16, 97.22, 58.65 and 54.87 ppm (Fig. 2). The
molecular ion peak was observed in agreement with the
molecular weight of the compound. The results indicated
that a series of substituted aromatic aldehydes were suc-
cessfully employed to prepare the corresponding product
in excellent yields (83–94%) and there is no major effect
on the yield of product by electron donating/withdrawing
substituents.
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Table 1
Synthesis of pyrano[2,3-d]pyrimidine derivatives 4(a–j).
Aldehyde Product Time (min) Yield (%)a M.P. (◦C)
Found Reported
103 83 235–236 238–239 [26]
 
110 86 239–241 262–263 [31]
101 84 231–234 257–258 [28]
53 94 158–160 163–167 [30]
67 91 169–171 170–174 [30]
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Table 1 (Continued)
Aldehyde Product Time (min) Yield (%)a M.P. (◦C)
Found Reported
72 89 228–232 235–236 [20]
58 94 236–238 224–225 [31]
67 91 289–293 290–293[30]
59 87 301–303 230 [16]
78 93 312–314 303–306 [30]
a Isolated yields.
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Table 2
Effect of catalysts for the synthesis of model product 4d using aqueous ethanol.a
Entry Catalyst Catalyst (mol%) Time (min) Yield (%)b
1 N-methylamidazole 20 mol 114 79
2 Triethylamine 20 mol 83 90
3 Piperidine 20 mol 110 71
4 Morpholine 20 mol 140 68
5 Dibutylamine 5 mol 105 74
6 Dibutylamine 10 mol 68 86
7 Dibutylamine 15 mol 53 87
8 Dibutylamine 20 mol 53 94
9 Catalyst free – 189 37
a Reaction conditions: hydroxybenzaldehyde (1 mmol), malononitrile (mmol), barbituric acid (1 mmol), DBA (20 mol%), aqueous ethanol,
stirring/reflux, r.t.
b Isolated yields.
Scheme 2. Synthesis of model product 4d using different catalysts in aqueous ethanol.
Fig. 1. 1H NMR spectra of 7-amino-5-(4-hydroxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitril (4d).
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ioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitril (4d).
Table 3
Optimization of different solvents for the model reaction.a
Entry Solvent Time (min) Yield (%)b
1 EtOH–H2O 53 94
3 DMF 59 61
4 CH2Cl2 103 58
5 1,4-Dioxane 72 63
6 Solvent less 192 57
a Reaction conditions: hydroxybenzaldehyde, malononitrile, bar-Fig. 2. 13C NMR spectra of 7-amino-5-(4-hydroxyphenyl)-2,4-d
Dibutylamine (DBA) is an amine that is basic in
character, so it facilitates proton removal from active
methylene compounds, thereby increasing the reaction
rate yields of the desired products. Mechanistically, DBA
is an effective catalyst for the formation of the higher
reactive iminium group, which is utilized to facilitate
the Knoevenagel condensation of malononitrile with aro-
matic aldehydes by loss of a water molecule, followed by
Michael addition of barbituric acid on an electron defi-
cient C-atom and an intra-molecular heterocyclization
that leads to the formation of the pyrano[2,3-
d]pyrimidine derivatives. A plausible mechanism
bituric acid (each 1 mol), DBA (20 mol%), aqueous ethanol,
strring/reflux, r.t.
b Yields based on isolated yields.
Table 4
DBA comparison with different catalysts for the synthesis of pyrano[2,3-d]pyrimidine derivatives.
Entry Catalyst Solvent Condition Time Yield Lit. Ref.
1 Zn[(l)proline]2 EtOH Reflux 30 min–12 h 80–92 [16]
2 [BMIm]BF4 [BMIm]BF4 90 ◦C 3–5 h 82–95 [17]
3 N-methylmorpholine [bmim][PF6] 70 ◦C 15 min 85–89 [18]
4 DAHP EtOH r.t. 2 h 71–81 [19]
5 SBA-Pr-SO3H Solvent free 140 ◦C 5–45 min 91 [20]
6 H14[NaP5W30O110] EtOH Reflux 30–60 min 85–90 [21]
7 1,4-Dioxane H2O Reflux 1–2 min 60–70 [22]
8 l-Proline Aq. EtOH Reflux 30–120 68–85 [23]
9 [K Al(SO4)2] H2O 80 ◦C 30–45 min 81–88 [24]
10 Et3N DMF MW 10–12 min 65–70 [25]
11 DBA Aq. EtOH Reflux 43–129 min 83–94 Present work
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.  Conclusion
In conclusion, we have synthesized pyrano[2,3-
]pyrimidine derivatives via a one-pot, three-component
omino Knoevenagel–Michael addition reaction using
ibutylamine (DBA) as a new efficient catalyst in aque-
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nd is devoid of any hazardous chemicals.cknowledgements
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